Show simple item record

dc.contributor.authorDeer, Rachel R.
dc.contributor.authorLiu, Feifan
dc.contributor.authorHaendel, Melissa
dc.contributor.authorRobinson, Peter N.
dc.date2022-08-11T08:08:28.000
dc.date.accessioned2022-08-23T15:55:56Z
dc.date.available2022-08-23T15:55:56Z
dc.date.issued2021-06-29
dc.date.submitted2021-08-18
dc.identifier.citation<p>medRxiv 2021.06.23.21259416; doi: https://doi.org/10.1101/2021.06.23.21259416. <a href="https://doi.org/10.1101/2021.06.23.21259416" target="_blank" title="view in medRxiv">Link to preprint on medRxiv</a></p>
dc.identifier.doi10.1101/2021.06.23.21259416
dc.identifier.urihttp://hdl.handle.net/20.500.14038/29864
dc.description<p>This article is a preprint. Preprints are preliminary reports of work that have not been certified by peer review.</p> <p>Full author list omitted for brevity. For the full list of authors, see article.</p>
dc.description.abstractImportance Since late 2019, the novel coronavirus SARS-CoV-2 has given rise to a global pandemic and introduced many health challenges with economic, social, and political consequences. In addition to a complex acute presentation that can affect multiple organ systems, there is mounting evidence of various persistent long-term sequelae. The worldwide scientific community is characterizing a diverse range of seemingly common long-term outcomes associated with SARS-CoV-2 infection, but the underlying assumptions in these studies vary widely making comparisons difficult. Numerous publications describe the clinical manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC or “long COVID”), but they are difficult to integrate because of heterogeneous methods and the lack of a standard for denoting the many phenotypic manifestations of long COVID. Observations We identified 303 articles published before April 29, 2021, curated 59 relevant manuscripts that described clinical manifestations in 81 cohorts of individuals three weeks or more following acute COVID-19, and mapped 287 unique clinical findings to Human Phenotype Ontology (HPO) terms. Conclusions and Relevance Patients and clinicians often use different terms to describe the same symptom or condition. Addressing the heterogeneous and inconsistent language used to describe the clinical manifestations of long COVID combined with the lack of standardized terminologies for long COVID will provide a necessary foundation for comparison and meta-analysis of different studies. Translating long COVID manifestations into computable HPO terms will improve the analysis, data capture, and classification of long COVID patients. If researchers, clinicians, and patients share a common language, then studies can be compared or pooled more effectively. Furthermore, mapping lay terminology to HPO for long COVID manifestations will help patients assist clinicians and researchers in creating phenotypic characterizations that are computationally accessible, which may improve the stratification and thereby diagnosis and treatment of long COVID.
dc.language.isoen_US
dc.relation<p>Now published in <em>EBioMedicine</em> doi: <a href="https://doi.org/10.1016/j.ebiom.2021.103722" target="_blank">10.1016/j.ebiom.2021.103722</a></p>
dc.rightsThe copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectInfectious Diseases
dc.subjectCOVID-19
dc.subjectlong COVID
dc.subjectpost-acute sequelae of SARS-CoV-2 infection
dc.subjectPASC
dc.subjectclinical manifestations
dc.subjectphenotyping
dc.subjectBioinformatics
dc.subjectComputational Biology
dc.subjectData Science
dc.subjectDiagnosis
dc.subjectImmunology and Infectious Disease
dc.subjectInfectious Disease
dc.subjectMicrobiology
dc.subjectVirus Diseases
dc.titleCharacterizing Long COVID: Deep Phenotype of a Complex Condition [preprint]
dc.typePreprint
dc.source.journaltitlemedRxiv
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=3090&amp;context=faculty_pubs&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/faculty_pubs/2071
dc.identifier.contextkey24380623
refterms.dateFOA2022-08-23T15:55:56Z
html.description.abstract<p><p id="x-x-x-x-x-p-2"><strong>Importance</strong> Since late 2019, the novel coronavirus SARS-CoV-2 has given rise to a global pandemic and introduced many health challenges with economic, social, and political consequences. In addition to a complex acute presentation that can affect multiple organ systems, there is mounting evidence of various persistent long-term sequelae. The worldwide scientific community is characterizing a diverse range of seemingly common long-term outcomes associated with SARS-CoV-2 infection, but the underlying assumptions in these studies vary widely making comparisons difficult. Numerous publications describe the clinical manifestations of post-acute sequelae of SARS-CoV-2 infection (PASC or “long COVID”), but they are difficult to integrate because of heterogeneous methods and the lack of a standard for denoting the many phenotypic manifestations of long COVID. <p id="x-x-x-x-x-p-3"><strong>Observations</strong> We identified 303 articles published before April 29, 2021, curated 59 relevant manuscripts that described clinical manifestations in 81 cohorts of individuals three weeks or more following acute COVID-19, and mapped 287 unique clinical findings to Human Phenotype Ontology (HPO) terms. <p id="x-x-x-x-x-p-4"><strong>Conclusions and Relevance</strong> Patients and clinicians often use different terms to describe the same symptom or condition. Addressing the heterogeneous and inconsistent language used to describe the clinical manifestations of long COVID combined with the lack of standardized terminologies for long COVID will provide a necessary foundation for comparison and meta-analysis of different studies. Translating long COVID manifestations into computable HPO terms will improve the analysis, data capture, and classification of long COVID patients. If researchers, clinicians, and patients share a common language, then studies can be compared or pooled more effectively. Furthermore, mapping lay terminology to HPO for long COVID manifestations will help patients assist clinicians and researchers in creating phenotypic characterizations that are computationally accessible, which may improve the stratification and thereby diagnosis and treatment of long COVID.</p>
dc.identifier.submissionpathfaculty_pubs/2071
dc.contributor.departmentDepartment of Population and Quantitative Health Sciences


Files in this item

Thumbnail
Name:
2021.06.23.21259416v1.full.pdf
Size:
551.0Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Except where otherwise noted, this item's license is described as The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.